Department: Biostatistics • Epidemiology
Title: Assistant Professor | Director of Graduate Studies for the DrPH Program
Email Address: firstname.lastname@example.org
Phone: (859) 218-3825
Location: Sanders-Brown Center on Aging, Room 230
Dr. Abner is an Assistant Professor in the Department of Epidemiology in the College of Public Health and also holds a joint appointment in the Sanders-Brown Center on Aging and in the Graduate Center for Gerontology. Dr. Abner received her Master of Public Health in Biostatistics from the University of Kentucky (2006), and her Ph.D. degree in Epidemiology & Biostatistics from the University of Kentucky (2013). She also received a Master of Arts in English Literature from the University of Kentucky (2002).
Dr. Abner's current research interests include clinicopathological correlations, the use of Markov chains in longitudinal data analysis, practice effects in cognitive screening instruments, and the relationship between cognitive impairment and self-rated quality of life. She focuses in the clinical area of Alzheimer’s disease and associated disorders and has a general interest in aging research.
Caldwell Book Award for Excellence in Infectious Disease Epidemiology (2013)
Delta Omega Public Health Honor Society (2006)
Abner EL, Nelson PT, Schmitt DA, Browning SR, Fardo DW, Wan L, Jicha GA, Cooper GE, Smith CD, Caban-Holt AM, Van Eldki LJ, Kryscio RJ. Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohort. Dement Geriatr Cog Disord 2013; In press.
Abner EL, Charnigo RJ, Krysio RJ. Markov chains and semi-Markov models in time-to-event analysis. J Biomet Biostat 2013; e001 [Epub].
Nelson PT, Smith CD, Abner EL, Wilfred BW, Wang W-X, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 2013;126:161-177.
Mathews M, Abner E, Caban-Holt A, Kryscio R, Schmitt F. CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatr 2013;Apr 10: 1-9.
Kryscio RJ, Abner EL, Lin Y, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. J Alz Dis 2013;[Epub ahead of print].
Abner EL, Dennis BC, Mathews MJ, Mendiondo MS, Caban-Holt A, Kryscio RJ, Schmitt FA, Crowley JJ. Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial. Trials 2012;13:217.
Abner EL, Kryscio RJ, Cooper GE, Fardo DW, Jicha GA, Mendiondo MS, Nelson PT, Smith CD, Van Eldik LJ, Wan L, Schmitt FA. Mild cognitive impairment: Statistical models of transition. Int J Alzheimer’s Dis 2012;doi:2012:291920.
Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson PT. “End-Stage” neurofibrillary tangle pathology in preclinical Alzheimer’s disease: Fact or fiction? J Alzheimers Dis 2011.
Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ. Vitamin E and all-cause mortality: A meta-analysis. Current Aging Science 2011;4(2):158-70.